Study of a new drug for chemo nausea and vomiting
Part of Cancer clinical trials.
This trial tests a medication called LY3537021 to see if it can prevent nausea and vomiting caused by certain types of chemotherapy (AC or cisplatin) in people who have not had chemo before. It focuses on patients who are otherwise in fairly good health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have never had chemotherapy before.
- Your planned chemotherapy includes AC or cisplatin, given on one day followed by 4 days of rest.
- You are able to take care of daily activities (ECOG score 0-2).
- You do not have untreated or active brain tumors causing symptoms.
- You do not have uncontrolled diabetes, significant heart issues, or a history of thyroid tumors.
- You have not taken GIP or GLP-1 drugs (like Ozempic) in the last 4 weeks.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new anti-nausea drug (HR20013) in patients receiving chemotherapy that often causes nausea and vomiting. It aims to see how well it works in real-world conditions, including for patients with liver problems.
This trial studies whether palonosetron helps prevent nausea and vomiting caused by chemotherapy that has a moderate risk of vomiting. It may help you feel more comfortable during chemo and avoid treatment interruptions from severe nausea.
This study tests an anti-nausea drug (nano-crystalline megestrol acetate) to see if it helps prevent nausea and vomiting caused by chemotherapy in people with stomach cancer. If you are starting your first chemotherapy, this may help you feel better during treatment.
This trial tests if giving anti-nausea drugs based on your genetic makeup can better prevent vomiting and nausea from chemotherapy for early breast cancer. You will receive a personalized regimen tailored to your pharmacogenetic profile.
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
This trial tests a medicine called IV NEPA (fosnetupitant/palonosetron) to prevent nausea and vomiting in children who are receiving strong chemotherapy. Patients will receive at least one cycle of chemotherapy that is highly likely to cause these side effects.
Hear when a new Nausea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.